16-13947884-C-T
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4
The NM_005236.3(ERCC4):c.2288C>T(p.Pro763Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000805 in 1,614,052 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_005236.3 missense
Scores
Clinical Significance
Conservation
Publications
- xeroderma pigmentosum group FInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, ClinGen
- Fanconi anemia complementation group QInheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- XFE progeroid syndromeInheritance: AR Classification: STRONG Submitted by: Ambry Genetics
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- xeroderma pigmentosumInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- xeroderma pigmentosum-Cockayne syndrome complexInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ERCC4 | NM_005236.3 | c.2288C>T | p.Pro763Leu | missense_variant | Exon 11 of 11 | ENST00000311895.8 | NP_005227.1 | |
| ERCC4 | XM_011522424.4 | c.2426C>T | p.Pro809Leu | missense_variant | Exon 12 of 12 | XP_011520726.1 | ||
| ERCC4 | XM_047433774.1 | c.1499C>T | p.Pro500Leu | missense_variant | Exon 8 of 8 | XP_047289730.1 | ||
| ERCC4 | XM_011522427.2 | c.938C>T | p.Pro313Leu | missense_variant | Exon 6 of 6 | XP_011520729.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ERCC4 | ENST00000311895.8 | c.2288C>T | p.Pro763Leu | missense_variant | Exon 11 of 11 | 1 | NM_005236.3 | ENSP00000310520.7 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152170Hom.: 1 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461882Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727240 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152170Hom.: 1 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74342 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Cockayne syndrome;C0268140:Xeroderma pigmentosum, group F;C3808988:Fanconi anemia complementation group Q Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 763 of the ERCC4 protein (p.Pro763Leu). This variant is present in population databases (rs761087753, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with ERCC4-related conditions. ClinVar contains an entry for this variant (Variation ID: 569796). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on ERCC4 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Inborn genetic diseases Uncertain:1
The c.2288C>T (p.P763L) alteration is located in exon 11 (coding exon 11) of the ERCC4 gene. This alteration results from a C to T substitution at nucleotide position 2288, causing the proline (P) at amino acid position 763 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at